JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 50 filers reported holding JANUX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,389,772 | -10.2% | 9,165,652 | +5.7% | 1.82% | -6.4% |
| Q2 2023 | $102,920,544 | -1.9% | 8,670,644 | 0.0% | 1.94% | -18.2% |
| Q1 2023 | $104,914,792 | -8.1% | 8,670,644 | 0.0% | 2.38% | +2.5% |
| Q4 2022 | $114,192,381 | -2.7% | 8,670,644 | 0.0% | 2.32% | -7.5% |
| Q3 2022 | $117,401,000 | +10.9% | 8,670,644 | 0.0% | 2.50% | -11.3% |
| Q2 2022 | $105,869,000 | -14.9% | 8,670,644 | 0.0% | 2.82% | +4.1% |
| Q1 2022 | $124,337,000 | -27.3% | 8,670,644 | 0.0% | 2.71% | -10.0% |
| Q4 2021 | $171,072,000 | -8.8% | 8,670,644 | 0.0% | 3.02% | +16.0% |
| Q3 2021 | $187,546,000 | -13.3% | 8,670,644 | 0.0% | 2.60% | -25.1% |
| Q2 2021 | $216,333,000 | – | 8,670,644 | – | 3.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $117,401,000 | 2.50% |
| 5AM Venture Management, LLC | 446,266 | $6,042,000 | 1.16% |
| Samsara BioCapital, LLC | 360,414 | $4,880,000 | 1.14% |
| BVF INC/IL | 1,470,334 | $19,908,000 | 0.82% |
| Orbimed Advisors | 2,836,386 | $38,405,000 | 0.71% |
| EcoR1 Capital, LLC | 1,421,319 | $19,245,000 | 0.57% |
| Woodline Partners LP | 400,181 | $5,418,000 | 0.08% |
| Parkwood LLC | 33,352 | $452,000 | 0.07% |
| JANUS HENDERSON GROUP PLC | 3,920,088 | $26,572,546 | 0.02% |
| Cerity Partners LLC | 105,933 | $1,434,000 | 0.02% |